Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort.
Ankylosing spondylitis
Axial spondyloarthritis
Biological treatment
Diet
Mediterranean diet
PREDIMED questionnaire
Patient education
Psoriasis
Psoriatic arthritis
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
20 08 2021
20 08 2021
Historique:
received:
20
03
2021
accepted:
03
08
2021
entrez:
21
8
2021
pubmed:
22
8
2021
medline:
7
9
2021
Statut:
epublish
Résumé
Little evidence is available about the impact of diet on disease activity of axial spondyloarthritis (axSpA). This study evaluated the impact of a 6-month nutritional advice based on the Mediterranean diet on the disease activity of axSpA. We prospectively collected the information of a group of axSpA patients who were offered nutritional advice for a 6-month period, who were compared to axSpA patients followed at the same center who were not on a specific diet. A nutritionist gave suggestions for dietary modification at baseline and thereafter every 2 months until month 6. Adherence to the Mediterranean diet was evaluated with the PREDIMED questionnaire ranging from 0 (no adherence) to 10 (optimal adherence); disease activity was evaluated with ASDAS-CRP. A multivariable regression analysis was conducted to identify independent predictors of PREDIMED and of ASDAS-CRP improvement (improvement ≥ 20% of each score). A total of 161 patients were included: 81 receiving nutritional advice and 80 controls; 47 in the nutritional group and 63 controls had complete information until month 6. Overall, 40 (36.4%) were females, the mean age was 51.7 ± 1.3 years, and 58 (52.7%) were affected with psoriasis. No relevant change of anthropometric or laboratory measures was observed in either group. Adherence to the Mediterranean diet was moderate (PREDIMED score 6.7 ± 1.8 at baseline; 7.6 ± 2.1 at month 6) and improved more in the nutritional group compared to controls (p = 0.020). Predictors of a PREDIMED improvement ≥ 20% were receiving nutritional advice (OR 4.53, 1.36-15.1, p = 0.014), age (per 10-year increase OR 1.05, 1.02-1.68, p = 0.007), and BMI (OR 0.77, 0.63-0.9, p = 0.006). An ASDAS-CRP improvement ≥ 20% was more frequent in the nutritional group compared to controls (p = 0.020). A PREDIMED improvement ≥ 20% was associated with a ASDAS-CRP improvement ≥ 20% (OR 6.75,1.8-25.3, p = 0.005). Psoriasis and disease duration were negatively but not significantly associated to the ASDAS-CRP improvement. Improving adherence to the Mediterranean diet may have a beneficial impact on the activity of axSpA. Patients with a lower BMI and older patients are less prone to modify their diet towards the Mediterranean diet following nutritional advice. Patients with psoriasis may have a limited benefit from dietary improvement. Protocol No. 52723, Padova Hospital Medical Ethical Committee (October 11, 2010).
Sections du résumé
BACKGROUND
Little evidence is available about the impact of diet on disease activity of axial spondyloarthritis (axSpA). This study evaluated the impact of a 6-month nutritional advice based on the Mediterranean diet on the disease activity of axSpA.
METHODS
We prospectively collected the information of a group of axSpA patients who were offered nutritional advice for a 6-month period, who were compared to axSpA patients followed at the same center who were not on a specific diet. A nutritionist gave suggestions for dietary modification at baseline and thereafter every 2 months until month 6. Adherence to the Mediterranean diet was evaluated with the PREDIMED questionnaire ranging from 0 (no adherence) to 10 (optimal adherence); disease activity was evaluated with ASDAS-CRP. A multivariable regression analysis was conducted to identify independent predictors of PREDIMED and of ASDAS-CRP improvement (improvement ≥ 20% of each score).
RESULTS
A total of 161 patients were included: 81 receiving nutritional advice and 80 controls; 47 in the nutritional group and 63 controls had complete information until month 6. Overall, 40 (36.4%) were females, the mean age was 51.7 ± 1.3 years, and 58 (52.7%) were affected with psoriasis. No relevant change of anthropometric or laboratory measures was observed in either group. Adherence to the Mediterranean diet was moderate (PREDIMED score 6.7 ± 1.8 at baseline; 7.6 ± 2.1 at month 6) and improved more in the nutritional group compared to controls (p = 0.020). Predictors of a PREDIMED improvement ≥ 20% were receiving nutritional advice (OR 4.53, 1.36-15.1, p = 0.014), age (per 10-year increase OR 1.05, 1.02-1.68, p = 0.007), and BMI (OR 0.77, 0.63-0.9, p = 0.006). An ASDAS-CRP improvement ≥ 20% was more frequent in the nutritional group compared to controls (p = 0.020). A PREDIMED improvement ≥ 20% was associated with a ASDAS-CRP improvement ≥ 20% (OR 6.75,1.8-25.3, p = 0.005). Psoriasis and disease duration were negatively but not significantly associated to the ASDAS-CRP improvement.
CONCLUSIONS
Improving adherence to the Mediterranean diet may have a beneficial impact on the activity of axSpA. Patients with a lower BMI and older patients are less prone to modify their diet towards the Mediterranean diet following nutritional advice. Patients with psoriasis may have a limited benefit from dietary improvement.
STUDY REGISTRATION
Protocol No. 52723, Padova Hospital Medical Ethical Committee (October 11, 2010).
Identifiants
pubmed: 34416917
doi: 10.1186/s13075-021-02600-0
pii: 10.1186/s13075-021-02600-0
pmc: PMC8377333
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
219Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021. The Author(s).
Références
Danve A, Deodhar AA. Complementary medicine for axial spondyloarthritis: is there any scientific evidence? Curr Opin Rheumatol. 2018;30(4):310–8. https://doi.org/10.1097/BOR.0000000000000513 .
doi: 10.1097/BOR.0000000000000513
pubmed: 29634580
pmcid: 29634580
Pocovi-Gerardino G, Correa-Rodríguez M, Callejas-Rubio J-L, Ríos-Fernández R, Martín-Amada M, Cruz-Caparros M-G, et al. Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study. Rheumatology. 2020;60(1):160–9. https://doi.org/10.1093/rheumatology/keaa210 .
doi: 10.1093/rheumatology/keaa210
Petersson S, Philippou E, Rodomar C, Nikiphorou E. The Mediterranean diet, fish oil supplements and rheumatoid arthritis outcomes: evidence from clinical trials. Autoimmun Rev. 2018;17:1105–14.
doi: 10.1016/j.autrev.2018.06.007
Vranou P, Gkoutzourelas A, Athanatou D, Zafiriou E, Grammatikopoulou MG, Bogdanos DP. Let food be thy medicine: the case of the Mediterranean diet in rheumatoid arthritis. Mediterr J Rheumatol. 2020;31(3):325–9. https://doi.org/10.31138/mjr.31.3.325 .
doi: 10.31138/mjr.31.3.325
pubmed: 33163865
pmcid: 33163865
Vedder D, Walrabenstein W, Heslinga M, de Vries R, Nurmohamed M, van Schaardenburg D, et al. Dietary interventions for gout and effect on cardiovascular risk factors: a systematic review. Nutrients. 2019;11(12). https://doi.org/10.3390/nu11122955 .
Venetsanopoulou AI, Voulgari PV, Drosos AA. Fasting mimicking diets: a literature review of their impact on inflammatory arthritis. Mediterr J Rheumatol. 2019;30(4):201–6. https://doi.org/10.31138/mjr.30.4.201 .
doi: 10.31138/mjr.30.4.201
pubmed: 32467870
pmcid: 32467870
Khanna S, Jaiswal KS, Gupta B. Managing rheumatoid arthritis with dietary interventions. Front Nutr. 2017;4:52. https://doi.org/10.3389/fnut.2017.00052 .
doi: 10.3389/fnut.2017.00052
pubmed: 29167795
pmcid: 29167795
Linos A, Kaklamani VG, Kaklamani E, Koumantaki Y, Giziaki E, Papazoglou S, et al. Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables? Am J Clin Nutr. 1999;70(6):1077–82. https://doi.org/10.1093/ajcn/70.6.1077 .
doi: 10.1093/ajcn/70.6.1077
pubmed: 10584053
pmcid: 10584053
Nguyen Y, Salliot C, Gelot A, Gambaretti J, Mariette X, Boutron-Ruault M-C, et al. Mediterranean diet and risk of rheumatoid arthritis: findings from the French E3N-EPIC cohort study. Arthritis Rheumatol. 2021;73(1):69–77. https://doi.org/10.1002/art.41487 .
doi: 10.1002/art.41487
pubmed: 32909390
pmcid: 32909390
Rosillo MA, Sánchez-Hidalgo M, Sánchez-Fidalgo S, Aparicio-Soto M, Villegas I, Alarcón-de-la-Lastra C. Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix degradation in murine collagen-induced arthritis. Eur J Nutr. 2016;55(1):315–25. https://doi.org/10.1007/s00394-015-0850-0 .
doi: 10.1007/s00394-015-0850-0
pubmed: 25665892
pmcid: 25665892
Di Giuseppe D, Wallin A, Bottai M, Askling J, Wolk A. Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. Ann Rheum Dis. 2014;73(11):1949–53. https://doi.org/10.1136/annrheumdis-2013-203338 .
doi: 10.1136/annrheumdis-2013-203338
pubmed: 23940215
pmcid: 23940215
Petersson S, Philippou E, Rodomar C, Nikiphorou E. The Mediterranean diet, fish oil supplements and rheumatoid arthritis outcomes: evidence from clinical trials. Autoimmun Rev. 2018;17(11):1105–14. https://doi.org/10.1016/j.autrev.2018.06.007 .
doi: 10.1016/j.autrev.2018.06.007
pubmed: 30213690
pmcid: 30213690
Proudman SM, James MJ, Spargo LD, Metcalf MG, Sullivan TR, Rischmueller M, et al. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Ann Rheum Dis. 2015;74(1):89–95. https://doi.org/10.1136/annrheumdis-2013-204145 .
doi: 10.1136/annrheumdis-2013-204145
pubmed: 24081439
pmcid: 24081439
Gladman DD, Ang M, Su L, Tom BDM, Schentag CT, Farewell VT. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis. 2009;68:1131 LP–135 Available from: http://ard.bmj.com/content/68/7/1131.abstract .
doi: 10.1136/ard.2008.094839
Papagoras C, Markatseli TE, Saougou I, Alamanos Y, Zikou AK, Voulgari PV, et al. Cardiovascular risk profile in patients with spondyloarthritis. Jt bone spine. 2014;81(1):57–63. https://doi.org/10.1016/j.jbspin.2013.03.019 .
doi: 10.1016/j.jbspin.2013.03.019
Papagoras C, Voulgari PV, Drosos AA. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol. 2013;31(4):612–20.
pubmed: 23406817
pmcid: 23406817
Martínez-González MA, García-Arellano A, Toledo E, Salas-Salvadó J, Buil-Cosiales P, Corella D, et al. A 14-item mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS One. 2012;7(8):e43134. https://doi.org/10.1371/journal.pone.0043134 .
doi: 10.1371/journal.pone.0043134
pubmed: 22905215
pmcid: 22905215
D’Alessandro A, De Pergola G. Mediterranean diet pyramid: a proposal for italian people. Nutrients. 2014;6(10):4302–16. https://doi.org/10.3390/nu6104302 .
doi: 10.3390/nu6104302
pubmed: 25325250
pmcid: 25325250
Ometto F, Raffeiner B, Azzolina D, Botsios C, Astorri D, Friso L, et al. Adherence in rheumatoid arthritis patients assessed with a validated Italian version of the 5-item Compliance Questionnaire for Rheumatology. Clin Exp Rheumatol. Italy. 2019;37:915–22.
Peters MJL, Symmons DPM, McCarey D, Dijkmans BAC, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69(2):325–31. https://doi.org/10.1136/ard.2009.113696 .
doi: 10.1136/ard.2009.113696
pubmed: 19773290
pmcid: 19773290
Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R, . Cesana G, Giampaoli S, Gruppo di Ricerca del Progetto CUORE Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score. Ann Ist Super Sanita. 2004;40:393–399, 4.
pubmed: 15815105
pmcid: 15815105
Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(1):18–24. https://doi.org/10.1136/ard.2008.094870 .
doi: 10.1136/ard.2008.094870
pubmed: 18625618
pmcid: 18625618
Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011;70(1):47–53. https://doi.org/10.1136/ard.2010.138594 .
doi: 10.1136/ard.2010.138594
pubmed: 21068095
pmcid: 21068095
Caso F, Navarini L, Carubbi F, Picchianti-Diamanti A, Chimenti MS, Tasso M, et al. Mediterranean diet and psoriatic arthritis activity: a multicenter cross-sectional study. Rheumatol Int. 2020;40(6):951–8. https://doi.org/10.1007/s00296-019-04458-7 .
doi: 10.1007/s00296-019-04458-7
pubmed: 31605152
pmcid: 31605152
Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. The epidemiology of type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med. England. 2005;22(11):1581–8. https://doi.org/10.1111/j.1464-5491.2005.01731.x .
doi: 10.1111/j.1464-5491.2005.01731.x
McKellar G, Morrison E, McEntegart A, Hampson R, Tierney A, Mackle G, et al. A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. Ann Rheum Dis. 2007;66(9):1239–43. https://doi.org/10.1136/ard.2006.065151 .
doi: 10.1136/ard.2006.065151
pubmed: 17613557
pmcid: 17613557
Sköldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(3):208–14. https://doi.org/10.1136/ard.62.3.208 .
doi: 10.1136/ard.62.3.208
pubmed: 12594104
pmcid: 12594104
Porras M, Rada G, Durán J. Effects of Mediterranean diet on the treatment of rheumatoid arthritis. Medwave. 2019;19:e7640.
doi: 10.5867/medwave.2019.05.7639
Ortolan A, Lorenzin M, Felicetti M, Ramonda R. Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2020. https://doi.org/10.1002/acr.24416 .
Tosti V, Bertozzi B, Fontana L. Health benefits of the Mediterranean diet: metabolic and molecular mechanisms. Journals Gerontol - Ser A Biol Sci Med Sci. 2018;73(3):318–26. https://doi.org/10.1093/gerona/glx227 .
doi: 10.1093/gerona/glx227
Rogier R, Koenders MI, Abdollahi-Roodsaz S. Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res. 2015;2015:527696.
doi: 10.1155/2015/527696
Bartlett DB, Willis LH, Slentz CA, Hoselton A, Kelly L, Huebner JL, et al. Ten weeks of high-intensity interval walk training is associated with reduced disease activity and improved innate immune function in older adults with rheumatoid arthritis: a pilot study. Arthritis Res Ther. 2018;20(1):127. https://doi.org/10.1186/s13075-018-1624-x .
doi: 10.1186/s13075-018-1624-x
pubmed: 29898765
pmcid: 29898765
Sveaas SH, Bilberg A, Berg IJ, Provan SA, Rollefstad S, Semb AG, et al. High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients. Br J Sports Med. 2020;54(5):292–7. https://doi.org/10.1136/bjsports-2018-099943 .
doi: 10.1136/bjsports-2018-099943
pubmed: 30745314
pmcid: 30745314
Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957–70. https://doi.org/10.1056/NEJMra1505557 .
doi: 10.1056/NEJMra1505557
pubmed: 28273019
pmcid: 28273019
Marchesoni A, Olivieri I, Salvarani C, Pipitone N, D’Angelo S, Mathieu A, et al. Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology. Clin Exp Rheumatol. 2017;35:0991–1010.
Ortolan A, Lorenzin M, Tadiotto G, Russo FP, Oliviero F, Felicetti M, et al. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. Clin Rheumatol. 2019;38(10):2843–50. https://doi.org/10.1007/s10067-019-04646-7 .
doi: 10.1007/s10067-019-04646-7
pubmed: 31254236
pmcid: 31254236
Puato M, Ramonda R, Doria A, Rattazzi M, Faggin E, Balbi G, et al. Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. J Hum Hypertens. 2014;28(2):105–10. https://doi.org/10.1038/jhh.2013.62 .
doi: 10.1038/jhh.2013.62
pubmed: 23842084
pmcid: 23842084
Ortolan A, Ramonda R, Lorenzin M, Pesavento R, Spinazzè A, Felicetti M, et al. Subclinical atherosclerosis evolution during 5 years of anti-TNF-alpha treatment in psoriatic arthritis patients. Clin Exp Rheumatol. 2021;39(1):158–61.
pubmed: 32452348
pmcid: 32452348
Costa L, Ramonda R, Ortolan A, Favero M, Foti R, Visalli E, et al. Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment. Clin Rheumatol. Germany. 2019;38(9):2355–62. https://doi.org/10.1007/s10067-019-04663-6 .
doi: 10.1007/s10067-019-04663-6
Papagoras C, Voulgari PV, Drosos AA. Cardiovascular disease in spondyloarthritides. Curr Vasc Pharmacol. 2020;18(5):473–87. https://doi.org/10.2174/1570161117666190426164306 .
doi: 10.2174/1570161117666190426164306
pubmed: 31330576
pmcid: 31330576
de Campos OAM, Nazário NO, de Magalhães Souza Fialho SC, Fialho GL, De Oliveira FJS, De Castro GRW, et al. Assessment of cardiovascular risk in patients with rheumatoid arthritis using the SCORE risk index. Rev Bras Reumatol. 2016;56(2):138–44. https://doi.org/10.1016/j.rbr.2015.07.007 .
doi: 10.1016/j.rbr.2015.07.007
Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986;124(6):903–15. https://doi.org/10.1093/oxfordjournals.aje.a114480 .
doi: 10.1093/oxfordjournals.aje.a114480
pubmed: 3776973
pmcid: 3776973
Redelmeier DA, Dickinson VM. Determining whether a patient is feeling better: pitfalls from the science of human perception. J Gen Intern Med. 2011;26(8):900–6. https://doi.org/10.1007/s11606-011-1655-3 .
doi: 10.1007/s11606-011-1655-3
pubmed: 21336670
pmcid: 21336670